BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20463643)

  • 1. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.
    Gaston RS; Cecka JM; Kasiske BL; Fieberg AM; Leduc R; Cosio FC; Gourishankar S; Grande J; Halloran P; Hunsicker L; Mannon R; Rush D; Matas AJ
    Transplantation; 2010 Jul; 90(1):68-74. PubMed ID: 20463643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
    Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and implications of capillaritis during acute rejection of kidney allografts.
    Cosio FG; Lager DJ; Lorenz EC; Amer H; Gloor JM; Stegall MD
    Transplantation; 2010 May; 89(9):1088-94. PubMed ID: 20216485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.
    Akalin E; Dinavahi R; Dikman S; de Boccardo G; Friedlander R; Schroppel B; Sehgal V; Bromberg JS; Heeger P; Murphy B
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1261-7. PubMed ID: 17942771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.
    Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S
    Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
    Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
    Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
    Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and sensitivity of screening for anti-HLA antibodies in kidney allograft dysfunction.
    Viana H; Nolasco F; Santos MC; Carvalho F; Galvão MJ; Santos AR; Bordalo J; Dos Santos JR
    Transplant Proc; 2009 Apr; 41(3):859-61. PubMed ID: 19376372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d.
    Kayler LK; Kiss L; Sharma V; Mohanka R; Zeevi A; Girnita A; Shapiro R; Randhawa PS
    Transplantation; 2008 Mar; 85(6):813-20. PubMed ID: 18360261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and importance of c4d deposition in renal allograft dysfunction.
    Demirci C; Sen S; Sezak M; Sarsik B; Hoşcoşkun C; Töz H
    Transplant Proc; 2008; 40(1):174-7. PubMed ID: 18261578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
    Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.